Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Switzerland Daily Monitor.
Press releases published on June 19, 2025

Delfio sichert sich 1,5 Millionen Euro für Automatisierungsplattform im Einkauf von Unterhaltungselektronik
AMSTERDAM, NETHERLANDS, June 19, 2025 /EINPresswire.com/ -- Delfio, das niederländische Start-up, das den internationalen Großhandelsmarkt automatisiert, hat eine Pre-Seed-Investition in Höhe von 1,5 Millionen Euro vom Tech-Investor Peak erhalten. Die …

XS.com est couronné "Courtier le Plus Innovant" aux UF Awards - Global 2025
SWITZERLAND, June 19, 2025 /Business News/ -- XS.com, leader mondial dans le domaine de la FinTech et du trading en ligne, a reçu le prestigieux titre de "Courtier le Plus Innovant" lors de la cérémonie mondiale des UF Awards, qui s'est tenue à l' …

Meatable Joins London Climate Action Week 2025 with Strong Commitment to a Sustainable Future
LONDON, UNITED KINGDOM, June 19, 2025 /EINPresswire.com/ -- Meatable, a global leader in cultivated meat technology, is proud to announce its active participation in this year’s London Climate Action Week 2025, reinforcing its mission to satisfy the …

Memo Therapeutics AG to Present Interim Phase II Results of Potravitug for the Treatment of BKV Infection in Kidney Transplant Recipients in a Late Breaking Oral Presentation at the World Transplant Congress
PRESS RELEASE Memo Therapeutics AG to Present Interim Phase II Results of Potravitug for the Treatment of BKV Infection in Kidney Transplant Recipients in a Late Breaking Oral Presentation at the World Transplant Congress Schlieren / Zurich, Switzerland, …

Official Launch of 9S UNION – The Global Economic Alliance at GIFPP Forum
ZURICH, June 19, 2025 (GLOBE NEWSWIRE) -- The Global Investment Forum for Peace …

Addex Therapeutics Reports Q1 2025 Financial Results and Provides Corporate Update
Strong cash position of CHF2.8 million at end of Q1 2025 GABAB PAM chronic cough candidate demonstrated robust anti-tussive activity in disease models Regained rights to our phase 2 mGlu2 PAM asset, ADX71149 Indivior advanced GABAB PAM Substance use …